TALK ABOUT hypos

Novo Nordisk’s campaign shifted global perspectives on blood sugar management by highlighting the risks of hypoglycemia associated with insulin use in diabetes. Collaborating with Dr. Stewart B. Harris, the study involved 4,300 families to explore the wider impact on patients and their relatives.

A standout feature was an interactive card on a dedicated website, designed to initiate conversations among people with diabetes, their families, and healthcare professionals.